Public Health Innovation Lab (PHiL)’s Post

🚨 Happening TODAY at 11AM CT! 🚨 Join the Public Health Innovation Lab (PHiL) for The Silent Epidemic: The Need for a Stronger IFI Response. 🌍 Invasive fungal infections (IFI) are a global health crisis affecting millions, yet they remain underrecognized and underfunded. This webinar will dive into: 🔎 The impact of IFIs worldwide 📉 Gaps in the current response 💡 Strategies for stronger global & local efforts 💬 Hear from an expert panel: Dr. Tom Chiller (CDC) Dr. Eric Goosby (UCSF) Oddi Aasheim (GAFFI) 📅 Free registration is still open! Join the conversation to raise awareness and drive change. 🔗 Register now and join us at 11AM: https://hubs.ly/Q02ZkBH80 (Details will also be shared live, so don’t miss out!) #SilentEpidemic #IFIResponse #FungalInfections #PublicHealth

According to WHO, 'Disease X' is a placeholder name to signify the unknown upcoming potential agent adopted in February 2018 and shortlisted in blueprint priority diseases. Health experts have sounded an alarm about the global threat of the X-agent after the WHO coined this term. It is simply an unnamed agent or microbial threat that could cause a future epidemic even a pandemic and would cause 20 times more fatalities than Covid-19. Did you know, COVID-19 spread in 2020 and claimed about 2.5 million people's lives globally? This article is written by Syed Saad Ali Zaidi Read more : https://lnkd.in/dujSSQVz #iknoweverything #DiseaseX #newpandemic #blogpost #ResearchArticle #newdiscovery #scientificknowledge

Fungal diseases pose significant challenges, especially for individuals with weakened immune systems, often leading to a considerable impact on their quality of life. Addressing these challenges requires targeted approaches to prevention, diagnosis, and treatment to enhance health outcomes. Join us for this ECHO WARE session as Dr. Adamu Abba Adamu shares expert insights into the effective management of fungal diseases in immunosuppressed populations. click here to register and join the meeting: https:// bit.ly/3H04G4u #PHIS3 #ECHOWARE

I am delighted to share that my latest research, which was presented at #IDWeek2023, has now been published in #PLOS Neglected Tropical Diseases(#PNTD). The paper is entitled "One-year mortality and morbidities of severe fever with thrombocytopenia syndrome compared with other diseases: A nationwide cohort study in South Korea." Severe fever with thrombocytopenia syndrome (#SFTS) is an emerging tick-borne disease in East Asia with a high mortality rate ranging from 6% to 32%. While many SFTS-related deaths occur within the first 30 days, our research reveals that the disease burden extends beyond the acute phase. Patients often face ongoing health challenges even after being discharged from hospital. Our findings underscore the importance of recognising the post-acute burden of SFTS and provide valuable insights for developing comprehensive management strategies for both acute and post-acute care in SFTS patients. Such diseases have the potential to spread to other regions and can be new pandemic threats. I believe that paying attention to these #neglected tick-borne diseases will be extremely beneficial in addressing future global health issues. Many thanks to all the contributors to this research. Read the full paper here: https://lnkd.in/eXEAtpiv

📢 World Health Organization's first-ever guidelines for controlling Strongyloides stercoralis mark a major step in tackling this challenging soil-transmitted helminth as a public health issue.    For an in-depth look, expert Dr. @Arancha Amor explains the unique challenges in diagnosing and treating this parasite in The Lancet Infectious Diseases. Read more about the ongoing efforts to fight #strongyloidiasis and advance #globalhealth goals. https://lnkd.in/d7Nt6CzA

We were delighted to hear Dr. Mitali Mukerji and Dr. Seema Kapoor discuss the "Framework for Ayurgenomics in Rare Diseases." We were also honoured to have Dr. Manoj Nesari, as the guest of honour. He shared his concerns about rare diseases, their treatment, and the future scope of Ayurgenomics in curing rare diseases. Harsha K Rajasimha Narayanan Govindarajan Nisha Venugopal Reena Kartha Ramya T karur Indo US Organization for Rare Diseases (IndoUSrare) Watch the full video here: https://buff.ly/4cDewqz #webinar #indousrare #ayurgenomics #rarediseases #healthcarewebinar

Enlightening thoughts on how the oldest form of medicine collaborates with the one of the newest form of medicine 😊

Despite the National Policy for Rare Diseases (2021), only 48.7% of resources for centres of excellence were utilized between 2021 and 2024, says IORD CEO Prof. Ramaiah Muthyala in a webinar, as reported by DC on Dec 18, 2024. Read more: https://lnkd.in/gygfkZiR #raredisease #rarediseaseawareness

Postscript | The retrospective application of the outbreak narrative enables a nuanced understanding of contagion amid the widespread mortality, fear, and panic that pandemics bring. https://lnkd.in/dHws6i5y

😷 Infectious disease (ID) models have been the backbone of policy decisions during the #COVID19 pandemic. However, models often overlook variation in disease risk, health burden, and policy impact across social groups. 👩⚕️ Nonetheless, social determinants are becoming increasingly recognized as fundamental to the success of control strategies overall and to the mitigation of disparities. 📰 In this recent systematic review of 19 ID modelling guidelines, Miqdad Asaria and colleagues outline specific recommendations for policy makers to better consider social determinants to : 1) improve the predictive accuracy of models 2) understand heterogeneity of disease burden and policy impact 3) contextualize decision making 4) address inequalities, and 5) assess implementation challenges. Read the article in full here 👉 https://lnkd.in/eS3a-Hkm